Dr. Benjamin Bader
Managing Director, CEO
Vita
Benjamin brings 15+ years of pharma service and life science background into the ZAS family. He obtained his PhD at the University of Rostock (Germany) and Karolinska Institute (Stockholm) and worked in preclinical contract research in different leading positions before he was appointed as CEO at ZAS in 2018. He is responsible for the GLP test facility management and the director of manufacturing within the manufacturing authorization of ZAS. Furthermore, he is in the extended board of the German Quality Management Association e.V. (GQMA) and is heading the archiving working group. He is co-author of the GQMA manuscript on “Electronic Archiving in the GxP area” and invited public speaker on several national and international conferences.
